Till Örebro universitet

oru.seÖrebro universitets publikationer
Driftinformation
Ett driftavbrott i samband med versionsuppdatering är planerat till 17/11-2026, kl 12.00-13.00. Under den tidsperioden kommer DiVA inte att vara tillgängligt.
Ändra sökning
Länk till posten
Permanent länk

Direktlänk
Kumawat, Ashok KumarORCID iD iconorcid.org/0000-0002-2244-9816
Alternativa namn
Publikationer (10 of 59) Visa alla publikationer
Zegeye, M. M., Veettil, J. T., Paramel, G. V., Kurt, S., Salihovic, S., Ljungberg, L. U., . . . Sirsjö, A. (2026). IL-6 triggers lysosomal degradation of LDL-R and enhances LDL-C uptake in vascular endothelial cells via macropinocytosis. Molecular Medicine, 32(1), Article ID 65.
Öppna denna publikation i ny flik eller fönster >>IL-6 triggers lysosomal degradation of LDL-R and enhances LDL-C uptake in vascular endothelial cells via macropinocytosis
Visa övriga...
2026 (Engelska)Ingår i: Molecular Medicine, ISSN 1076-1551, E-ISSN 1528-3658, Vol. 32, nr 1, artikel-id 65Artikel i tidskrift (Refereegranskat) Published
Abstract [en]

Background: Endothelial dysfunction profoundly compromises the barrier function that precludes trans-endothelial entry of low-density lipoprotein cholesterol (LDL-C) into the vessel wall. LDL-C retention in the vessel wall is atherogenic and its flux involves several mechanisms including LDL-receptor (LDL-R) mediated transcytosis, a process that is facilitated by inflammatory stressors. In this study, we aimed to investigate the role of interleukin-6 (IL-6) in regulating LDL-R and LDL-C uptake by vascular endothelial cells.

Method: We used commercially available Human umbilical vein endothelial cells (HUVECs) in this study. Flow cytometry, western blotting, qRT-PCR and ELISA were used to investigate expression of LDL-R and Mylip/IDOL. LDL-C uptake and free cholesterol levels in HUVECs was assessed using flowcytometry and mass-spectrometry respectively.

Results: We show that HUVECs treated with a combination of IL-6 and soluble IL-6 receptor (sIL-6R) result in a significant reduction in surface expression of LDL-R, an effect that is reversed by soluble gp130Fc - an antagonist of IL-6 trans-singling. Using pharmacological inhibitors and gene silencing techniques, we demonstrate that IL-6 trans-signaling induced downregulation of LDL-R is attained through lysosomal degradation mediated by the E3 ubiquitin ligase Mylip. Conversely, HUVECs treated with IL-6 in combination with sIL-6R exhibit markedly increased uptake of native LDL-C which is also inhibited by sgp130Fc, the actin inhibitor Cytochalasin D and the macropinocytosis inhibitor EIPA. Although stimulation of HUVECs upregulated the expression of scavenger receptors CD36 and CXCL16, their contribution to native LDL-C uptake turned out to be negligible.

Conclusion: Collectively, this study highlights the role of IL-6 in the regulation of LDL-R expression and cholesterol homeostasis in vascular ECs. IL-6 trans-signaling downregulates LDL-R yet increases LDL-C uptake via an LDL-R-independent, actin-dependent macropinocytosis pathway.

Ort, förlag, år, upplaga, sidor
Springer, 2026
Nyckelord
Mylip/IDOL, Trans-signaling, Macropinocytosis, Atherosclerosis, Endothelial dysfunction
Nationell ämneskategori
Medicinsk bioteknologi (Inriktn. mot cellbiologi (inkl. stamcellsbiologi), molekylärbiologi, mikrobiologi, biokemi eller biofarmaci)
Identifikatorer
urn:nbn:se:oru:diva-128649 (URN)10.1186/s10020-026-01484-7 (DOI)001748845900001 ()42034979 (PubMedID)
Forskningsfinansiär
Örebro universitetKK-stiftelsen, 2018–0035KK-stiftelsen, 2021–0038
Anmärkning

Open access funding provided by Örebro University. This work was supported by Knowledge Foundation [KK Synergi17, Dnr 2018–0035 and KK Prospekt, Dnr 2021–0038].

Tillgänglig från: 2026-05-05 Skapad: 2026-05-05 Senast uppdaterad: 2026-05-05Bibliografiskt granskad
Kapetanaki, S., Salihovic, S., Kumawat, A. K., Massy, Z. A., Persson, K., Barany, P., . . . Demirel, I. (2025). Correlations Between Trimethylamine-N-Oxide, Megalin, Lysine and Markers of Tubular Damage in Chronic Kidney Disease. Toxins, 17(12), Article ID 592.
Öppna denna publikation i ny flik eller fönster >>Correlations Between Trimethylamine-N-Oxide, Megalin, Lysine and Markers of Tubular Damage in Chronic Kidney Disease
Visa övriga...
2025 (Engelska)Ingår i: Toxins, E-ISSN 2072-6651, Vol. 17, nr 12, artikel-id 592Artikel i tidskrift (Refereegranskat) Published
Abstract [en]

Trimethylamine-N-oxide (TMAO), a gut microbiota-derived dietary metabolite, is linked to progression of chronic kidney disease (CKD). Megalin, a renal proximal tubule receptor crucial for albumin reabsorption, also plays a role in CKD. However, the relationship between them is not well explored. The aim of this study was to investigate if there are any correlations between the levels of TMAO, megalin, lysine and markers of tubular damage in CKD. Urinary metabolites (TMAO, choline, L-carnitine, betaine, lysine) and tubular markers (megalin, albumin, EGF, MCP-1) were quantified by LC-MS/MS and ELISA. Associations were evaluated using analysis of covariance (ANCOVA) adjusted for age and diabetes, with false discovery rate correction. Compared with controls, CKD patients showed higher urinary choline (FDR < 0.001), betaine (FDR = 0.007), lysine (FDR = 0.005), and soluble megalin (FDR < 0.001) but lower EGF and EGF/MCP-1 ratio (both FDR < 0.001). Correlation analyses revealed that serum TMAO was positively associated with soluble megalin and negatively with EGF/MCP-1 ratio. Choline, L-carnitine, and betaine were positively correlated with megalin. This cross-sectional study identifies associations between urinary metabolites, megalin, and tubular injury markers in advanced CKD. Although causality cannot be inferred, the results point to a potential metabolic-tubular link that should be explored in future longitudinal and mechanistic studies.

Ort, förlag, år, upplaga, sidor
MDPI, 2025
Nyckelord
TMAO, albuminuria, chronic kidney disease, lysine, megalin, tubular damage
Nationell ämneskategori
Endokrinologi och diabetes
Identifikatorer
urn:nbn:se:oru:diva-125923 (URN)10.3390/toxins17120592 (DOI)001648218200001 ()41441627 (PubMedID)2-s2.0-105025732111 (Scopus ID)
Forskningsfinansiär
Örebro universitetKK-stiftelsenSvenska läkaresällskapet
Anmärkning

Funding Agencies:

This project was financially supported by the Faculty of Medicine and Health at Örebro University, the Swedish Knowledge Foundation, European Renal Association and the Swedish Medical Association.

Tillgänglig från: 2025-12-29 Skapad: 2025-12-29 Senast uppdaterad: 2026-01-23Bibliografiskt granskad
Reitsema, R. D., Kurt, S., Rangel, I., Hjelmqvist, H., Dreifaldt, M., Sirsjö, A. & Kumawat, A. K. (2025). Patients with peripheral artery disease demonstrate altered expression of soluble and membrane-bound immune checkpoints. Frontiers in Immunology, 16, Article ID 1568431.
Öppna denna publikation i ny flik eller fönster >>Patients with peripheral artery disease demonstrate altered expression of soluble and membrane-bound immune checkpoints
Visa övriga...
2025 (Engelska)Ingår i: Frontiers in Immunology, E-ISSN 1664-3224, Vol. 16, artikel-id 1568431Artikel i tidskrift (Refereegranskat) Published
Abstract [en]

INTRODUCTION: Studies suggest that immune checkpoints play a role in accelerating the formation of atherosclerosis. We aimed to assess the expression of soluble and membrane-bound immune checkpoints in patients with peripheral artery disease (PAD).

METHODS: The levels of 14 soluble immune checkpoints were assessed in blood plasma of PAD patients (n= 37) and healthy controls (HCs, n=39) by Multiplex protein assay. The surface expression of immune checkpoints on peripheral blood immune cells was determined by flow cytometry. Cytokine production capacity was measured by flow cytometry in TIM-3+ T cells to determine immune exhaustion.

RESULTS: Soluble levels of PD-L2 were decreased in female PAD patients, whereas soluble levels of TIM-3 showed a trend towards an increased concentration in female PAD patients. PD-L2+ frequencies were higher within all monocyte subsets in PAD patients. CD4+ T cells from PAD patients had increased frequencies of TIM-3+ cells, showing little overlap with other immune exhaustion markers. TIM-3+ CD4+ T cells from both PAD patients and HCs, had a low capacity to produce pro-inflammatory cytokines, but a higher capacity to produce IL-10 compared to TIM-3- CD4+ T cells.

CONCLUSION: PAD patients show differences in the expression of membrane-bound and soluble immune checkpoints. Some of these differences might be caused by prolonged immune activation, although immune exhaustion markers did not always overlap.

Ort, förlag, år, upplaga, sidor
Frontiers Media S.A., 2025
Nyckelord
T cells, antigen presenting cells, immune checkpoints, intermittent claudication, peripheral artery disease
Nationell ämneskategori
Immunologi inom det medicinska området
Identifikatorer
urn:nbn:se:oru:diva-122847 (URN)10.3389/fimmu.2025.1568431 (DOI)001543917300001 ()40761788 (PubMedID)2-s2.0-105012362856 (Scopus ID)
Forskningsfinansiär
Nyckelfonden, KK HÖG19, 2019-0085Nyckelfonden, OLL-999741Region Örebro län, OLL-996956
Tillgänglig från: 2025-08-20 Skapad: 2025-08-20 Senast uppdaterad: 2026-05-11Bibliografiskt granskad
Reitsema, R. D., Kumawat, A. K., Hesselink, B.-C., van Baarle, D. & van Sleen, Y. (2024). Effects of ageing and frailty on circulating monocyte and dendritic cell subsets. npj aging, 10(1), Article ID 17.
Öppna denna publikation i ny flik eller fönster >>Effects of ageing and frailty on circulating monocyte and dendritic cell subsets
Visa övriga...
2024 (Engelska)Ingår i: npj aging, E-ISSN 2731-6068, Vol. 10, nr 1, artikel-id 17Artikel i tidskrift (Refereegranskat) Published
Abstract [en]

Ageing is associated with dysregulated immune responses, resulting in impaired resilience against infections and low-grade inflammation known as inflammageing. Frailty is a measurable condition in older adults characterized by decreased health and physical impairment. Dendritic cells (DCs) and monocytes play a crucial role in initiating and steering immune responses. To assess whether their frequencies and phenotypes in the blood are affected by ageing or frailty, we performed a flow cytometry study on monocyte and DC subsets in an immune ageing cohort. We included (n = 15 in each group) healthy young controls (HYC, median age 29 years), healthy older controls (HOC, 73 years) and Frail older controls (76 years). Monocyte subsets (classical, intermediate, non-classical) were identified by CD14 and CD16 expression, and DC subsets (conventional (c)DC1, cDC2, plasmacytoid (p)DC) by CD11c, CD1c, CD141 and CD303 expression. All subsets were checked for TLR2, TLR4, HLA-DR, CD86, PDL1, CCR7 and CD40 expression. We observed a lower proportion of pDCs in HOC compared to HYC. Additionally, we found higher expression of activation markers on classical and intermediate monocytes and on cDC2 in HOC compared to HYC. Frail participants had a higher expression of CD40 on classical and non-classical monocytes compared to the HOC group. We document a substantial effect of ageing on monocytes and DCs. Reduced pDCs in older people may underlie their impaired ability to counter viral infections, whereas enhanced expression of activation markers could indicate a state of inflammageing. Future studies could elucidate the functional consequences of CD40 upregulation with frailty.

Ort, förlag, år, upplaga, sidor
Nature Publishing Group, 2024
Nationell ämneskategori
Immunologi inom det medicinska området
Identifikatorer
urn:nbn:se:oru:diva-112127 (URN)10.1038/s41514-024-00144-6 (DOI)001178127600001 ()38438383 (PubMedID)2-s2.0-85186629789 (Scopus ID)
Forskningsfinansiär
EU, Horisont 2020
Anmärkning

This research has been performed in the context of the VITAL consortium. The VITAL project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No. 806776 and the Dutch Ministry of Health, Welfare and Sport. The JU receives support from the European Union's Horizon 2020 research and innovation program and EFPIA-members.

Tillgänglig från: 2024-03-06 Skapad: 2024-03-06 Senast uppdaterad: 2024-03-20Bibliografiskt granskad
Hayderi, A., Kumawat, A. K., Shavva, V. S., Dreifaldt, M., Sigvant, B., Petri, M., . . . Ljungberg, L. (2024). RSAD2 is abundant in atherosclerotic plaques and promotes interferon-induced CXCR3-chemokines in human smooth muscle cells. Scientific Reports, 14(1), Article ID 8196.
Öppna denna publikation i ny flik eller fönster >>RSAD2 is abundant in atherosclerotic plaques and promotes interferon-induced CXCR3-chemokines in human smooth muscle cells
Visa övriga...
2024 (Engelska)Ingår i: Scientific Reports, E-ISSN 2045-2322, Vol. 14, nr 1, artikel-id 8196Artikel i tidskrift (Refereegranskat) Published
Abstract [en]

In atherosclerotic lesions, monocyte-derived macrophages are major source of interferon gamma (IFN-γ), a pleotropic cytokine known to regulate the expression of numerous genes, including the antiviral gene RSAD2. While RSAD2 was reported to be expressed in endothelial cells of human carotid lesions, its significance for the development of atherosclerosis remains utterly unknown. Here, we harnessed publicly available human carotid atherosclerotic data to explore RSAD2 in lesions and employed siRNA-mediated gene-knockdown to investigate its function in IFN-γ-stimulated human aortic smooth muscle cells (hAoSMCs). Silencing RSAD2 in IFN-γ-stimulated hAoSMCs resulted in reduced expression and secretion of key CXCR3-chemokines, CXCL9, CXCL10, and CXCL11. Conditioned medium from RSAD2-deficient hAoSMCs exhibited diminished monocyte attraction in vitro compared to conditioned medium from control cells. Furthermore, RSAD2 transcript was elevated in carotid lesions where it was expressed by several different cell types, including endothelial cells, macrophages and smooth muscle cells. Interestingly, RSAD2 displayed significant correlations with CXCL10 (r =  0.45, p = 0.010) and CXCL11 (r = 0.53, p = 0.002) in human carotid lesions. Combining our findings, we uncover a novel role for RSAD2 in hAoSMCs, which could potentially contribute to monocyte recruitment in the context of atherosclerosis.

Ort, förlag, år, upplaga, sidor
Nature Publishing Group, 2024
Nationell ämneskategori
Kardiologi och kardiovaskulära sjukdomar
Identifikatorer
urn:nbn:se:oru:diva-113037 (URN)10.1038/s41598-024-58592-9 (DOI)001198838600052 ()38589444 (PubMedID)2-s2.0-85189798266 (Scopus ID)
Forskningsfinansiär
Örebro universitetKK-stiftelsen, 20180035Stiftelsen Gamla Tjänarinnor, 2020-01074; 2021-01198Stiftelsen Sigurd och Elsa Goljes minne, LA2020-0196Sjukvårdsregionala forskningsrådet Mellansverige, RFR-750481; RFR-940393
Tillgänglig från: 2024-04-09 Skapad: 2024-04-09 Senast uppdaterad: 2025-02-10Bibliografiskt granskad
Kapetanaki, S., Kumawat, A. K., Paramel Varghese, G., Persson, K. & Demirel, I. (2024). TMAO enhances TNF-α mediated fibrosis and release of inflammatory mediators from renal fibroblasts. Scientific Reports, 14(1), Article ID 9070.
Öppna denna publikation i ny flik eller fönster >>TMAO enhances TNF-α mediated fibrosis and release of inflammatory mediators from renal fibroblasts
Visa övriga...
2024 (Engelska)Ingår i: Scientific Reports, E-ISSN 2045-2322, Vol. 14, nr 1, artikel-id 9070Artikel i tidskrift (Refereegranskat) Published
Abstract [en]

Trimethylamine-N-oxide (TMAO) is a gut microbiota-derived metabolite and TNF-α is proinflammatory cytokine, both known to be associated with renal inflammation, fibrosis and chronic kidney disease. However, today there are no data showing the combined effect of TMAO and TNF-α on renal fibrosis-and inflammation. The aim of this study was to investigate whether TMAO can enhance the inflammatory and fibrotic effects of TNF-α on renal fibroblasts. We found that the combination of TNF-α and TMAO synergistically increased fibronectin release and total collagen production from renal fibroblasts. The combination of TMAO and TNF-α also promoted increased cell proliferation. Both renal proliferation and collagen production were mediated through Akt/mTOR/ERK signaling. We also found that TMAO enhanced TNF-α mediated renal inflammation by inducing the release of several cytokines (IL-6, LAP TGF-beta-1), chemokines (CXCL-6, MCP-3), inflammatory-and growth mediators (VEGFA, CD40, HGF) from renal fibroblasts. In conclusion, we showed that TMAO can enhance TNF-α mediated renal fibrosis and release of inflammatory mediators from renal fibroblasts in vitro. Our results can promote further research evaluating the combined effect of TMAO and inflammatory mediators on the development of kidney disease.

Ort, förlag, år, upplaga, sidor
Nature Publishing Group, 2024
Nyckelord
Fibrosis, Inflammation, Renal fibroblasts, TMAO, TNF-α
Nationell ämneskategori
Klinisk medicin
Identifikatorer
urn:nbn:se:oru:diva-113326 (URN)10.1038/s41598-024-58084-w (DOI)001207737100003 ()38643262 (PubMedID)2-s2.0-85190774511 (Scopus ID)
Forskningsfinansiär
Örebro universitet
Tillgänglig från: 2024-04-22 Skapad: 2024-04-22 Senast uppdaterad: 2026-03-19Bibliografiskt granskad
Hayderi, A., Zegeye, M. M., Meydan, S., Sirsjö, A., Kumawat, A. K. & Ljungberg, L. (2024). TNF Induces Laminin-332-Encoding Genes in Endothelial Cells and Laminin-332 Promotes an Atherogenic Endothelial Phenotype. International Journal of Molecular Sciences, 25(16), Article ID 8699.
Öppna denna publikation i ny flik eller fönster >>TNF Induces Laminin-332-Encoding Genes in Endothelial Cells and Laminin-332 Promotes an Atherogenic Endothelial Phenotype
Visa övriga...
2024 (Engelska)Ingår i: International Journal of Molecular Sciences, ISSN 1661-6596, E-ISSN 1422-0067, Vol. 25, nr 16, artikel-id 8699Artikel i tidskrift (Refereegranskat) Published
Abstract [en]

Laminins are essential components of the basement membranes, expressed in a tissue- and cell-specific manner under physiological conditions. During inflammatory circumstances, such as atherosclerosis, alterations in laminin composition within vessels have been observed. Our study aimed to assess the influence of tumor necrosis factor-alpha (TNF), a proinflammatory cytokine abundantly found in atherosclerotic lesions, on endothelial laminin gene expression and the effects of laminin-332 (LN332) on endothelial cells' behavior. We also evaluated the expression of LN332-encoding genes in human carotid atherosclerotic plaques. Our findings demonstrate that TNF induces upregulation of LAMB3 and LAMC2, which, along with LAMA3, encode the LN332 isoform. Endothelial cells cultured on recombinant LN332 exhibit decreased claudin-5 expression and display a loosely connected phenotype, with an elevated expression of chemokines and leukocyte adhesion molecules, enhancing their attractiveness and adhesion to leukocytes in vitro. Furthermore, LAMB3 and LAMC2 are upregulated in human carotid plaques and show a positive correlation with TNF expression. In summary, TNF stimulates the expression of LN332-encoding genes in human endothelial cells and LN332 promotes an endothelial phenotype characterized by compromised junctional integrity and increased leukocyte interaction. These findings highlight the importance of basement membrane proteins for endothelial integrity and the potential role of LN332 in atherosclerosis.

Ort, förlag, år, upplaga, sidor
MDPI, 2024
Nyckelord
ECM, activated endothelial cells, atherosclerosis, laminin-5, monocytes migration
Nationell ämneskategori
Cell- och molekylärbiologi
Identifikatorer
urn:nbn:se:oru:diva-115699 (URN)10.3390/ijms25168699 (DOI)001305177900001 ()39201392 (PubMedID)2-s2.0-85202650459 (Scopus ID)
Forskningsfinansiär
KK-stiftelsen, 2018-0035; 2018-0139Stiftelsen Gamla Tjänarinnor, 2020-01074; 2021-01198Stiftelsen Sigurd och Elsa Goljes minne, LA2020-0196
Tillgänglig från: 2024-09-02 Skapad: 2024-09-02 Senast uppdaterad: 2024-11-04Bibliografiskt granskad
Thazhathveettil, J., Kumawat, A. K., Demirel, I., Sirsjö, A. & Paramel Varghese, G. (2024). Vascular smooth muscle cells in response to cholesterol crystals modulates inflammatory cytokines release and promotes neutrophil extracellular trap formation. Molecular Medicine, 30(1), Article ID 42.
Öppna denna publikation i ny flik eller fönster >>Vascular smooth muscle cells in response to cholesterol crystals modulates inflammatory cytokines release and promotes neutrophil extracellular trap formation
Visa övriga...
2024 (Engelska)Ingår i: Molecular Medicine, ISSN 1076-1551, E-ISSN 1528-3658, Vol. 30, nr 1, artikel-id 42Artikel i tidskrift (Refereegranskat) Published
Abstract [en]

BACKGROUND: The formation and accumulation of cholesterol crystals (CC) at the lesion site is a hallmark of atherosclerosis. Although studies have shown the importance of vascular smooth muscle cells (VSMCs) in the disease atherosclerosis, little is known about the molecular mechanism behind the uptake of CC in VSMCs and their role in modulating immune response.

METHODS: Human aortic smooth muscle cells were cultured and treated with CC. CC uptake and CC mediated signaling pathway and protein induction were studied using flow cytometry, confocal microscopy, western blot and Olink proteomics. Conditioned medium from CC treated VSMCs was used to study neutrophil adhesion, ROS production and phagocytosis. Neutrophil extracellular traps (NETs) formations were visualized using confocal microscopy.

RESULTS: VSMCs and macrophages were found around CC clefts in human carotid plaques. CC uptake in VSMCs are largely through micropinocytosis and phagocytosis via PI3K-AkT dependent pathway. The uptake of CC in VSMCs induce the release inflammatory proteins, including IL-33, an alarming cytokine. Conditioned medium from CC treated VSMCs can induce neutrophil adhesion, neutrophil reactive oxygen species (ROS) and neutrophil extracellular traps (NETs) formation. IL-33 neutralization in conditioned medium from CC treated VSMCs inhibited neutrophil ROS production and NETs formation.

CONCLUSION: We demonstrate that VSMCs due to its vicinity to CC clefts in human atherosclerotic lesion can modulate local immune response and we further reveal that the interaction between CC and VSMCs impart an inflammatory milieu in the atherosclerotic microenvironment by promoting IL-33 dependent neutrophil influx and NETs formation.

Ort, förlag, år, upplaga, sidor
BioMed Central (BMC), 2024
Nyckelord
Atherosclerosis, Cardiovascular disease, Cholesterol crystal, Inflammation, Interleukin-33 (IL-33), Neutrophil extracellular traps, Neutrophils, Vascular smooth muscle cells
Nationell ämneskategori
Cell- och molekylärbiologi
Identifikatorer
urn:nbn:se:oru:diva-112553 (URN)10.1186/s10020-024-00809-8 (DOI)001189265700002 ()38519881 (PubMedID)2-s2.0-85188471703 (Scopus ID)
Forskningsfinansiär
Örebro universitetKK-stiftelsen, 20190120; 20220014Stiftelsen Gamla Tjänarinnor, dnr 2021-01166; dnr 2022-01329
Tillgänglig från: 2024-03-25 Skapad: 2024-03-25 Senast uppdaterad: 2024-04-03Bibliografiskt granskad
Thazhathveettil, J., Kumawat, A., Demirel, I., Sirsjö, A. & Paramel, G. (2023). Cholesterol crystals uptake in vascular smooth muscle cells modulates local immune responses. Paper presented at 91st Annual Meeting of the European-Atherosclerosis-Society (EAS 2023), Mannheim, Germany, May 21-24, 2023. Atherosclerosis, 379(Suppl. 1), S9-S9, Article ID SS026.
Öppna denna publikation i ny flik eller fönster >>Cholesterol crystals uptake in vascular smooth muscle cells modulates local immune responses
Visa övriga...
2023 (Engelska)Ingår i: Atherosclerosis, ISSN 0021-9150, E-ISSN 1879-1484, Vol. 379, nr Suppl. 1, s. S9-S9, artikel-id SS026Artikel i tidskrift, Meeting abstract (Övrigt vetenskapligt) Published
Ort, förlag, år, upplaga, sidor
Elsevier, 2023
Nationell ämneskategori
Kardiologi och kardiovaskulära sjukdomar
Identifikatorer
urn:nbn:se:oru:diva-109553 (URN)001060595800112 ()
Konferens
91st Annual Meeting of the European-Atherosclerosis-Society (EAS 2023), Mannheim, Germany, May 21-24, 2023
Tillgänglig från: 2023-11-06 Skapad: 2023-11-06 Senast uppdaterad: 2025-02-10Bibliografiskt granskad
Kurt, S., Pirronello, F., Reitsema, R., Demirel, I., Rangel, I., Sirsjö, A., . . . Kumawat, A. (2023). Increased proportion of circulating neutrophils with impaired phagocytosis capacity in patients with peripheral arterial disease. Paper presented at 91st Annual Meeting of the European-Atherosclerosis-Society (EAS 2023), Mannheim, Germany, May 21-24, 2023. Atherosclerosis, 379(Suppl. 1), S22-S22, Article ID P068.
Öppna denna publikation i ny flik eller fönster >>Increased proportion of circulating neutrophils with impaired phagocytosis capacity in patients with peripheral arterial disease
Visa övriga...
2023 (Engelska)Ingår i: Atherosclerosis, ISSN 0021-9150, E-ISSN 1879-1484, Vol. 379, nr Suppl. 1, s. S22-S22, artikel-id P068Artikel i tidskrift, Meeting abstract (Övrigt vetenskapligt) Published
Abstract [en]

Background and Aims: Peripheral arterial disease (PAD) is a clinical manifestation of atherosclerosis, affecting arteries in the leg. Based on their symptoms and severity, PAD patients are characterized into three sub-groups: asymptomatic, intermittent claudication (IC) and critical limb ischemia (CLI). Despite its high prevalence, PAD remains under diagnosed and the role of immune cells in PAD pathophysiology remains poorly understood. In this study, we characterized the innate immune responses in PAD patients compared to healthy controls.

Methods: Blood samples were collected from 14 patients with PAD (IC) and 30 healthy controls, to assess the phenotype of monocytes and neutrophils by using 10-colour flow cytometry. Phagocytosis assay was performed with labelled E.coli particles. Mann-Whitney U non-parametrical test was used for statistical comparison between PAD patients and healthy controls.

Results: A significant higher proportion of leukocytes (p<0.05) and neutrophils (p<0.01) was observed in PAD patients compared to healthy controls, whereas monocyte subsets showed no significant differences. Interestingly, neutrophils showed a significantly impaired phagocytosis capability (p<0.05) and reduced expression of myeloperoxidase (MPO) (p<0.05) in PAD patients compared to healthy controls.

Conclusions: Taken together these results, suggest that PAD patients have an increased proportion of neutrophils in circulation, with impaired phagocytosis capability, compared to healthy controls.

Ort, förlag, år, upplaga, sidor
Elsevier, 2023
Nationell ämneskategori
Kardiologi och kardiovaskulära sjukdomar
Identifikatorer
urn:nbn:se:oru:diva-109555 (URN)001060595800354 ()
Konferens
91st Annual Meeting of the European-Atherosclerosis-Society (EAS 2023), Mannheim, Germany, May 21-24, 2023
Tillgänglig från: 2023-11-06 Skapad: 2023-11-06 Senast uppdaterad: 2025-02-10Bibliografiskt granskad
Organisationer
Identifikatorer
ORCID-id: ORCID iD iconorcid.org/0000-0002-2244-9816

Sök vidare i DiVA

Visa alla publikationer